Months after a federal ban went into effect outlawing a propellant used in most rescue inhalers, some asthma sufferers insist that the replacement inhalers don’t work and might even be harmful.

WASHINGTON — Old-fashioned asthma inhalers that contain environment-harming chemicals will no longer be sold at year’s end — and the government is urging patients not to wait until the last minute to ...

The U.S. Food and Drug Administration recently issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane or HFA-propelled albuterol ...

Time is running out for patients who use albuterol inhalers to replace those propelled by chlorofluorocarbons (CFCs) with ones that rely on eco-friendly hydrofluoroalkane (HFA). After December 31, ...

WASHINGTON (Reuters) - U.S. patients who use certain asthma inhalers made with ozone-depleting propellants should talk to their doctors now about alternatives ahead of a ban that starts in January, ...

GAINESVILLE, Fla. --- A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according ...

In an effort to plant a talking point in the next Republican presidential debate prevent damage to the ozone layer, the Obama administration will order the phase-out of an over-the-counter asthma ...

The Salamol easy-breathe CFC-free inhaler is designed to be a more environmental-friendly option for asthma sufferers, producing as little as 4% of the carbon footprint of alternative inhalers. This ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ASMOL INHALER contains the active ingredient salbutamol sulfate. ASMOL ...

Emergency asthma inhalers propelled by chlorofluorocarbons — known as CFCs — are going the way of the Styrofoam hamburger container. And that means a steep increase in insurance co-payments or ...

Asthmatics face a deadline of December 31, 2011 to switch from using epinephrine inhalers to other prescription treatment methods under an order from the Food and Drug Administration. At issue is the ...